Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Preclinical Development: Overview01:28

Preclinical Development: Overview

5.7K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
5.7K
Clinical Trials: Overview01:11

Clinical Trials: Overview

4.5K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.5K
Drug Discovery: Overview01:26

Drug Discovery: Overview

10.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.9K
Drug Administration and Therapy Phases: Overview01:26

Drug Administration and Therapy Phases: Overview

1.1K
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
1.1K
In Vitro Drug Release Testing: Overview, Development and Validation01:10

In Vitro Drug Release Testing: Overview, Development and Validation

279
In vitro dissolution and drug release tests assess how quickly and how much of a drug is released from its dosage form into an aqueous medium under standardized laboratory conditions. These tests are essential tools in pharmaceutical development and quality assurance, offering insight into the drug's performance before clinical use.During formulation development, dissolution testing identifies incomplete or inconsistent drug release issues. It also supports decisions on selecting the optimal...
279
Drug Regulation01:25

Drug Regulation

2.7K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
2.7K

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

The modulation of the blood-brain barrier by focused ultrasound stimulates oligodendrogenesis.

Acta neuropathologica communications·2026
Same author

Parametric optimization of transcranial focused ultrasound neuromodulation of the periaqueductal grey for blood pressure reduction.

Brain stimulation·2026
Same author

Focused ultrasound in pediatric neuro-oncology: Current applications and future directions.

Neuro-oncology advances·2026
Same author

Anti-focus driving signals to mitigate bone heating during focused ultrasound ablation of uterine fibroids with phased arrays.

Physics in medicine and biology·2026
Same author

Focused Ultrasound Treatment of Vitreous Hemorrhage in an In Vivo Rabbit Model.

Ophthalmology science·2026
Same author

Optimization of bacterial colonization in the gut of axenic and conventional zebrafish larvae using live food.

Microbiology spectrum·2026

関連する実験動画

Updated: Jan 7, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

10.1K

薬物開発

Malik White1,2, Rikke Han Kofoed3,4,5, Chinaza Lilian Dibia1,2

  • 1University of Toronto, Toronto, ON, Canada.

Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 26, 2025
PubMed
まとめ

静脈内投与アデノ随伴ウイルス（AAV）ベクターと集束超音波（FUS）の組み合わせは、血液脳関門を越えた遺伝子送達を強化します。この非侵襲的な方法により、脳疾患の精密または広範な遺伝子治療が可能になります。

キーワード:
薬物開発遺伝子治療血液脳関門アデノ随伴ウイルス集束超音波神経変性疾患アルツハイマー病パーキンソン病脳送達非侵襲的

さらに関連する動画

In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing
08:04

In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing

Published on: May 11, 2021

3.3K
Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells
05:45

Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells

Published on: October 10, 2025

451

関連する実験動画

Last Updated: Jan 7, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

10.1K
In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing
08:04

In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing

Published on: May 11, 2021

3.3K
Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells
05:45

Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells

Published on: October 10, 2025

451

科学分野:

  • 神経科学
  • 遺伝子治療
  • 医用画像処理

背景:

  • 組換えアデノ随伴ウイルス（AAV）は脳疾患に有望ですが、侵襲的送達と血液脳関門（BBB）浸透性の課題に直面しています。
  • 静脈内（i.v.）AAV送達は、BBBにより非効率的であり、治療範囲を制限します。
  • 新しいAAVバリアントとMRIガイド集束超音波（FUS）は、脳内導入の強化のための潜在的な解決策を提供します。

研究 の 目的:

  • 神経変性疾患の治療のために、広範および領域特異的な遺伝子導入の両方を達成すること。
  • 神経変性疾患の治療のために、脳への遺伝子送達を最適化するために、i.v. BBB浸透性AAVとFUSの組み合わせた有効性を調査すること。

主な方法:

  • C57BL/6マウスにi.v. AAV-PHP.V1.CAG.TdTomato（V1）およびAAV9.CAG.EYFPを投与しました。
  • 注射後に標的とする脳領域に集束超音波（FUS）を適用しました。
  • 免疫組織化学および共焦点顕微鏡検査を用いて、投与3週間後の分析を行いました。

主要な成果:

  • FUSは、AAV9およびV1ベクターの両方で標的遺伝子送達を大幅に強化しました。
  • V1ベクターは、FUSによる局所的な濃縮と並行して、脳全体の維持された発現を示しました。
  • この組み合わせアプローチは、精密（AAV9）または広範（V1）な遺伝子治療のための非侵襲的な戦略を提供します。

結論:

  • この組み合わせAAVおよびFUS戦略は、BBBを越えた遺伝子送達効率を向上させます。
  • このアプローチは、アルツハイマー病やパーキンソン病などの神経変性疾患の治療強化の可能性を秘めています。